Global Genomic Cancer Testing Market Research Report 2023

Report ID: 1198111 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Genomic Cancer Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Fluorescence In Situ Hybridization
        1.2.3 Polymerase Chain Reaction
        1.2.4 Microarray Technology
        1.2.5 Serum Proteomics
        1.2.6 Nucleic Acid Sequencing
    1.3 Market by Application
        1.3.1 Global Genomic Cancer Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Speciality Clinics
        1.3.4 Research Institutes
        1.3.5 Diagnostics Laboratories
        1.3.6 Biopharmaceutical Companies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Genomic Cancer Testing Market Perspective (2017-2028)
    2.2 Genomic Cancer Testing Growth Trends by Region
        2.2.1 Genomic Cancer Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Genomic Cancer Testing Historic Market Size by Region (2017-2022)
        2.2.3 Genomic Cancer Testing Forecasted Market Size by Region (2023-2028)
    2.3 Genomic Cancer Testing Market Dynamics
        2.3.1 Genomic Cancer Testing Industry Trends
        2.3.2 Genomic Cancer Testing Market Drivers
        2.3.3 Genomic Cancer Testing Market Challenges
        2.3.4 Genomic Cancer Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Genomic Cancer Testing Players by Revenue
        3.1.1 Global Top Genomic Cancer Testing Players by Revenue (2017-2022)
        3.1.2 Global Genomic Cancer Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Genomic Cancer Testing Revenue
    3.4 Global Genomic Cancer Testing Market Concentration Ratio
        3.4.1 Global Genomic Cancer Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Genomic Cancer Testing Revenue in 2021
    3.5 Genomic Cancer Testing Key Players Head office and Area Served
    3.6 Key Players Genomic Cancer Testing Product Solution and Service
    3.7 Date of Enter into Genomic Cancer Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Cancer Testing Breakdown Data by Type
    4.1 Global Genomic Cancer Testing Historic Market Size by Type (2017-2022)
    4.2 Global Genomic Cancer Testing Forecasted Market Size by Type (2023-2028)
5 Genomic Cancer Testing Breakdown Data by Application
    5.1 Global Genomic Cancer Testing Historic Market Size by Application (2017-2022)
    5.2 Global Genomic Cancer Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Genomic Cancer Testing Market Size (2017-2028)
    6.2 North America Genomic Cancer Testing Market Size by Country (2017-2022)
    6.3 North America Genomic Cancer Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Genomic Cancer Testing Market Size (2017-2028)
    7.2 Europe Genomic Cancer Testing Market Size by Country (2017-2022)
    7.3 Europe Genomic Cancer Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Genomic Cancer Testing Market Size (2017-2028)
    8.2 Asia-Pacific Genomic Cancer Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Genomic Cancer Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Genomic Cancer Testing Market Size (2017-2028)
    9.2 Latin America Genomic Cancer Testing Market Size by Country (2017-2022)
    9.3 Latin America Genomic Cancer Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Genomic Cancer Testing Market Size (2017-2028)
    10.2 Middle East & Africa Genomic Cancer Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Genomic Cancer Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Devyser
        11.1.1 Devyser Company Detail
        11.1.2 Devyser Business Overview
        11.1.3 Devyser Genomic Cancer Testing Introduction
        11.1.4 Devyser Revenue in Genomic Cancer Testing Business (2017-2022)
        11.1.5 Devyser Recent Development
    11.2 Agendia
        11.2.1 Agendia Company Detail
        11.2.2 Agendia Business Overview
        11.2.3 Agendia Genomic Cancer Testing Introduction
        11.2.4 Agendia Revenue in Genomic Cancer Testing Business (2017-2022)
        11.2.5 Agendia Recent Development
    11.3 Illumina
        11.3.1 Illumina Company Detail
        11.3.2 Illumina Business Overview
        11.3.3 Illumina Genomic Cancer Testing Introduction
        11.3.4 Illumina Revenue in Genomic Cancer Testing Business (2017-2022)
        11.3.5 Illumina Recent Development
    11.4 Personal Genome Diagnostics
        11.4.1 Personal Genome Diagnostics Company Detail
        11.4.2 Personal Genome Diagnostics Business Overview
        11.4.3 Personal Genome Diagnostics Genomic Cancer Testing Introduction
        11.4.4 Personal Genome Diagnostics Revenue in Genomic Cancer Testing Business (2017-2022)
        11.4.5 Personal Genome Diagnostics Recent Development
    11.5 Veracyte
        11.5.1 Veracyte Company Detail
        11.5.2 Veracyte Business Overview
        11.5.3 Veracyte Genomic Cancer Testing Introduction
        11.5.4 Veracyte Revenue in Genomic Cancer Testing Business (2017-2022)
        11.5.5 Veracyte Recent Development
    11.6 Pacific Biosciences of California
        11.6.1 Pacific Biosciences of California Company Detail
        11.6.2 Pacific Biosciences of California Business Overview
        11.6.3 Pacific Biosciences of California Genomic Cancer Testing Introduction
        11.6.4 Pacific Biosciences of California Revenue in Genomic Cancer Testing Business (2017-2022)
        11.6.5 Pacific Biosciences of California Recent Development
    11.7 Qiagen
        11.7.1 Qiagen Company Detail
        11.7.2 Qiagen Business Overview
        11.7.3 Qiagen Genomic Cancer Testing Introduction
        11.7.4 Qiagen Revenue in Genomic Cancer Testing Business (2017-2022)
        11.7.5 Qiagen Recent Development
    11.8 Agilent Technologies
        11.8.1 Agilent Technologies Company Detail
        11.8.2 Agilent Technologies Business Overview
        11.8.3 Agilent Technologies Genomic Cancer Testing Introduction
        11.8.4 Agilent Technologies Revenue in Genomic Cancer Testing Business (2017-2022)
        11.8.5 Agilent Technologies Recent Development
    11.9 Natera
        11.9.1 Natera Company Detail
        11.9.2 Natera Business Overview
        11.9.3 Natera Genomic Cancer Testing Introduction
        11.9.4 Natera Revenue in Genomic Cancer Testing Business (2017-2022)
        11.9.5 Natera Recent Development
    11.10 Bio Rad Laboratories
        11.10.1 Bio Rad Laboratories Company Detail
        11.10.2 Bio Rad Laboratories Business Overview
        11.10.3 Bio Rad Laboratories Genomic Cancer Testing Introduction
        11.10.4 Bio Rad Laboratories Revenue in Genomic Cancer Testing Business (2017-2022)
        11.10.5 Bio Rad Laboratories Recent Development
    11.11 Myriad Genetics
        11.11.1 Myriad Genetics Company Detail
        11.11.2 Myriad Genetics Business Overview
        11.11.3 Myriad Genetics Genomic Cancer Testing Introduction
        11.11.4 Myriad Genetics Revenue in Genomic Cancer Testing Business (2017-2022)
        11.11.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Genomic Cancer Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Fluorescence In Situ Hybridization
    Table 3. Key Players of Polymerase Chain Reaction
    Table 4. Key Players of Microarray Technology
    Table 5. Key Players of Serum Proteomics
    Table 6. Key Players of Nucleic Acid Sequencing
    Table 7. Global Genomic Cancer Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Genomic Cancer Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Genomic Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Genomic Cancer Testing Market Share by Region (2017-2022)
    Table 11. Global Genomic Cancer Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Genomic Cancer Testing Market Share by Region (2023-2028)
    Table 13. Genomic Cancer Testing Market Trends
    Table 14. Genomic Cancer Testing Market Drivers
    Table 15. Genomic Cancer Testing Market Challenges
    Table 16. Genomic Cancer Testing Market Restraints
    Table 17. Global Genomic Cancer Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Genomic Cancer Testing Market Share by Players (2017-2022)
    Table 19. Global Top Genomic Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2021)
    Table 20. Ranking of Global Top Genomic Cancer Testing Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Genomic Cancer Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Genomic Cancer Testing Product Solution and Service
    Table 24. Date of Enter into Genomic Cancer Testing Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Genomic Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Genomic Cancer Testing Revenue Market Share by Type (2017-2022)
    Table 28. Global Genomic Cancer Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Genomic Cancer Testing Revenue Market Share by Type (2023-2028)
    Table 30. Global Genomic Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Genomic Cancer Testing Revenue Market Share by Application (2017-2022)
    Table 32. Global Genomic Cancer Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Genomic Cancer Testing Revenue Market Share by Application (2023-2028)
    Table 34. North America Genomic Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Genomic Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Genomic Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Genomic Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Genomic Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Genomic Cancer Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Genomic Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Genomic Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Genomic Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Genomic Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Devyser Company Detail
    Table 45. Devyser Business Overview
    Table 46. Devyser Genomic Cancer Testing Product
    Table 47. Devyser Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 48. Devyser Recent Development
    Table 49. Agendia Company Detail
    Table 50. Agendia Business Overview
    Table 51. Agendia Genomic Cancer Testing Product
    Table 52. Agendia Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 53. Agendia Recent Development
    Table 54. Illumina Company Detail
    Table 55. Illumina Business Overview
    Table 56. Illumina Genomic Cancer Testing Product
    Table 57. Illumina Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 58. Illumina Recent Development
    Table 59. Personal Genome Diagnostics Company Detail
    Table 60. Personal Genome Diagnostics Business Overview
    Table 61. Personal Genome Diagnostics Genomic Cancer Testing Product
    Table 62. Personal Genome Diagnostics Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 63. Personal Genome Diagnostics Recent Development
    Table 64. Veracyte Company Detail
    Table 65. Veracyte Business Overview
    Table 66. Veracyte Genomic Cancer Testing Product
    Table 67. Veracyte Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 68. Veracyte Recent Development
    Table 69. Pacific Biosciences of California Company Detail
    Table 70. Pacific Biosciences of California Business Overview
    Table 71. Pacific Biosciences of California Genomic Cancer Testing Product
    Table 72. Pacific Biosciences of California Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 73. Pacific Biosciences of California Recent Development
    Table 74. Qiagen Company Detail
    Table 75. Qiagen Business Overview
    Table 76. Qiagen Genomic Cancer Testing Product
    Table 77. Qiagen Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 78. Qiagen Recent Development
    Table 79. Agilent Technologies Company Detail
    Table 80. Agilent Technologies Business Overview
    Table 81. Agilent Technologies Genomic Cancer Testing Product
    Table 82. Agilent Technologies Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 83. Agilent Technologies Recent Development
    Table 84. Natera Company Detail
    Table 85. Natera Business Overview
    Table 86. Natera Genomic Cancer Testing Product
    Table 87. Natera Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 88. Natera Recent Development
    Table 89. Bio Rad Laboratories Company Detail
    Table 90. Bio Rad Laboratories Business Overview
    Table 91. Bio Rad Laboratories Genomic Cancer Testing Product
    Table 92. Bio Rad Laboratories Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 93. Bio Rad Laboratories Recent Development
    Table 94. Myriad Genetics Company Detail
    Table 95. Myriad Genetics Business Overview
    Table 96. Myriad Genetics Genomic Cancer TestingProduct
    Table 97. Myriad Genetics Revenue in Genomic Cancer Testing Business (2017-2022) & (US$ Million)
    Table 98. Myriad Genetics Recent Development
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Genomic Cancer Testing Market Share by Type: 2021 VS 2028
    Figure 2. Fluorescence In Situ Hybridization Features
    Figure 3. Polymerase Chain Reaction Features
    Figure 4. Microarray Technology Features
    Figure 5. Serum Proteomics Features
    Figure 6. Nucleic Acid Sequencing Features
    Figure 7. Global Genomic Cancer Testing Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Speciality Clinics Case Studies
    Figure 10. Research Institutes Case Studies
    Figure 11. Diagnostics Laboratories Case Studies
    Figure 12. Biopharmaceutical Companies Case Studies
    Figure 13. Genomic Cancer Testing Report Years Considered
    Figure 14. Global Genomic Cancer Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Genomic Cancer Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Genomic Cancer Testing Market Share by Region: 2021 VS 2028
    Figure 17. Global Genomic Cancer Testing Market Share by Players in 2021
    Figure 18. Global Top Genomic Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Genomic Cancer Testing Revenue in 2021
    Figure 20. North America Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Genomic Cancer Testing Market Share by Country (2017-2028)
    Figure 22. United States Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Genomic Cancer Testing Market Share by Country (2017-2028)
    Figure 26. Germany Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Genomic Cancer Testing Market Share by Region (2017-2028)
    Figure 34. China Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Genomic Cancer Testing Market Share by Country (2017-2028)
    Figure 42. Mexico Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Genomic Cancer Testing Market Share by Country (2017-2028)
    Figure 46. Turkey Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Genomic Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Devyser Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 49. Agendia Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 50. Illumina Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 51. Personal Genome Diagnostics Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 52. Veracyte Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 53. Pacific Biosciences of California Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 54. Qiagen Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 55. Agilent Technologies Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 56. Natera Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 57. Bio Rad Laboratories Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 58. Myriad Genetics Revenue Growth Rate in Genomic Cancer Testing Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Frequently Asked Questions
Genomic Cancer Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Genomic Cancer Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Genomic Cancer Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Endoscopic Snare

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Pelvic Ring Fixation

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More